← Leaderboards
Xin Shelley Wang
University Of Texas Md Anderson Can Ctr
$3,667,610
Attributed
$3,667,610
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $653.7K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,667,610 · 4
By mechanism
R01$2,566,216 · 1
R21$1,101,394 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Karen M Basen-Engquist$10,237,208
- Michael Jordan Fisch$0
- Eileen H Shinn$3,738,061
- Lorenzo Cohen$18,186,221
- Richard Swartz$661,833
Others in their field
Top investigators on “Measurement”
- Lawrence Corey · Fred Hutchinson Cancer Center$517,278,507
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$468,973,477
- David R. Weir · University Of Michigan At Ann Arbor$403,695,976
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$297,689,086
- Christopher McKay · Battelle Memorial Institute$290,340,771
- David H Reitze · University Of Florida$256,180,831
Research focus
MeasurementPathway InteractionsMalignant NeoplasmsSymptomsReportingCancer PatientClinical TrialsSeveritiesBaseRadiation OncologyInnovationFutureSymptom ManagementCaringPatient CareConsensusCancer TherapyCohortLeadResponseAffectAnimalsInflammationInflammatory
Grant awards (10)
Improving Recovery after Major Cancer Surgery using Patient-Reported Outcomes$626,375
R01 · FY2019 · CA · contact PI
Improving Recovery after Major Cancer Surgery using Patient-Reported Outcomes$653,676
R01 · FY2018 · CA · contact PI
Improving Recovery after Major Cancer Surgery using Patient-Reported Outcomes$648,005
R01 · FY2017 · CA · contact PI
Improving Recovery after Major Cancer Surgery using Patient-Reported Outcomes$638,160
R01 · FY2016 · CA · contact PI
Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients$161,516
R21 · FY2013 · CA · contact PI
Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients$206,190
R21 · FY2012 · CA · contact PI
Inflammatory Cytokines Associated Symptom Burden in NSCLC Patients Receiving CXRT$173,250
R21 · FY2009 · CA · contact PI
Inflammatory Cytokines Associated Symptom Burden in NSCLC Patients Receiving CXRT$207,900
R21 · FY2008 · CA · contact PI
Cytokines and Symptoms in Lung Cancer treatment$190,213
R21 · FY2006 · CA · contact PI
Cytokines and Symptoms in Lung Cancer treatment$162,325
R21 · FY2005 · CA